Medical, neurological, and psychiatric characteristics
| Patients on CEIs (%) | Patients who never used CEIs (%) | χ2 | p Value | |
|---|---|---|---|---|
| Extrapyramidal signs: | ||||
| Baseline: | 74 (55) | 90 (67) | 3.49 | 0.06 |
| Follow up | 101 (75) | 105 (78) | 0.32 | 0.56 |
| Psychosis: | ||||
| Baseline | 53 (39) | 59 (44) | 0.54 | 0.53 |
| Follow up | 68 (50) | 72 (53) | 0.23 | 0.62 |
| Major depression: | ||||
| Baseline | 19 (14) | 14 (10) | 0.86 | 0.35 |
| Follow up | 17 (13) | 11 (8) | 1.43 | 0.23 |
| Medication use: | ||||
| Sedatives | ||||
| Baseline | 14 (10) | 8 (6) | 1.72 | 0.18 |
| Follow up | 12 (9) | 17 (13) | 0.96 | 0.32 |
| Antidepressants | ||||
| Baseline | 39 (29) | 35 (26) | 0.29 | 0.58 |
| Follow up | 41 (30) | 35 (26) | 0.65 | 0.41 |
| Antipsychotics | ||||
| Baseline | 4 (3) | 14 (10) | 5.95 | 0.02 |
| Follow up | 10 (7) | 32 (26) | 13.6 | <0.001 |
| Hypertension | 45 (33) | 49 (36) | 0.26 | 0.60 |
| Diabetes mellitus | 3 (2) | 7 (5) | 0.66 | 0.69 |
| Ischaemic heart disease | 9 (7) | 12 (9) | 0.46 | 0.49 |
| Pulmonary disease | 4 (3) | 4 (3) | 0.00 | 1.00 |
| Stroke at follow up | 8 (6) | 11 (8) | 0.51 | 0.47 |